Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147

Acta Pharmacologica Sinica

Volumn 23, Issue 4, 2002, Pages 355-360

  Chen, Zhong ^a   Xu, A Jing ^a   Li, Ren ^a   Wei, Er Qing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cholinesterase inhibitors; Donepezil; Maze learning; Memory disorders; Tacrine; TAK 147

Indexed keywords

DONEPEZIL; SCOPOLAMINE; SODIUM CHLORIDE; TACRINE; ZANEPEZIL; BENZAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; LATENT PERIOD; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; RAT; SPATIAL MEMORY; ANIMAL; CHEMICALLY INDUCED DISORDER; MEMORY DISORDER; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BENZAZEPINES; CHOLINESTERASE INHIBITORS; INDANS; MALE; MAZE LEARNING; MEMORY DISORDERS; MOTOR ACTIVITY; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE; TACRINE;

EID: 0036206356     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Acetylcholine: A neurotransmitter for learning and memory?
2. Cholinergic correlates of cognitive impairment in Parkinson's disease: Comparisons with Alzheimer's disease
3. Human serial learning: Enhancement with arecholine and choline impairment with scopolamine
4. 3-receptor antagonist clobenpropit on spatial memory of radial maze performance in rats
5. Facilitating effects of histamine on spatial memory deficit induced by scopolamine in rats
6. Is there a rational for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?
7. Pharmacological profole of huperzine A, a novel acetylcholinesterase inhibitor from Chinese Herb
8. Comparative studies of huperzine A E2020, and tacrine on behavior and cholinesterase activities
9. Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: Comparison with E2020 and tacrine
10. Effect of rivastigmine on scopolamine-induced memory impairment in rats
11. Central cholinergic agents. 6. Synthesis and evaluation of 3-[1-(phenylmethyl)-4-piperidinyl]-1 (2, 3, 4, 5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone and their analogs as central selective acetylcholinesterase inhibitors
12. Preclinical pharmacology of TAK-147, a novel acetylcholinesterase inhibitor, as a protential therapeutic drug for Alzhermer's disease
13. TAK-147, an acetylcholinesterase inhibitor, increase choline acetyltransferase activity in cultured rat septal cholinergic neurons
14. Effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2, 3, 4, 5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models
15. Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1- (2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats
16. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats
17. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: Comparison with other cholinesterase inhibitors
18. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats
19. Central selective acetylcholinesterase inhibitor with neurotrophic activity: Structure-activity relationships of TAK-147 and related compounds